Evidence map›Paper›PMID 36190246›Full record

ArticleJournal of visualized experiments : JoVE2022

Modeling Human Cerebellar Development In Vitro in 2D Structure.

Deniz A Madencioglu, Karina A Kruth, Thomas H Wassink, Vincent A Magnotta, John A Wemmie, Aislinn J Williams

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Deniz A MadenciogluDepartment of Psychiatry, University of Iowa; Carver College of Medicine, University of Iowa; Iowa Neuroscience Institute, University of Iowa; Pappajohn Biomedical Institute, University of Iowa.
Karina A KruthDepartment of Psychiatry, University of Iowa; Carver College of Medicine, University of Iowa; Iowa Neuroscience Institute, University of Iowa; Pappajohn Biomedical Institute, University of Iowa.
Thomas H WassinkDepartment of Psychiatry, University of Iowa; Carver College of Medicine, University of Iowa.
Vincent A MagnottaDepartment of Psychiatry, University of Iowa; Department of Radiology, University of Iowa; Carver College of Medicine, University of Iowa; Iowa Neuroscience Institute, University of Iowa; Pappajohn Biomedical Institute, University of Iowa.
John A WemmieDepartment of Psychiatry, University of Iowa; Carver College of Medicine, University of Iowa; Iowa Neuroscience Institute, University of Iowa; Pappajohn Biomedical Institute, University of Iowa.
Aislinn J WilliamsDepartment of Psychiatry, University of Iowa; Carver College of Medicine, University of Iowa; Iowa Neuroscience Institute, University of Iowa; Pappajohn Biomedical Institute, University of Iowa; aislinn-williams@uiowa.edu.
University of Iowa · US

Funding

Cerebellar metabolism, neural circuits, and symptoms in bipolar disorderR01MH111578 · NIMH · UNIVERSITY OF IOWA · PI VINCENT A MAGNOTTA, John A Wemmie · 2017 to 2026
$5.7M
The Iowa Neuroscience Specialty Program in Research Education (INSPIRE)T32MH019113 · NIMH · UNIVERSITY OF IOWA · PI HANNA E STEVENS, John A Wemmie · 1991 to 2026
$5.6M
The University of Iowa Clinical and Translational Science AwardKL2TR002536 · NCATS · UNIVERSITY OF IOWA · PI BASSUK, ALEXANDER G · 2018 to 2022
$3.3M
NCATS NIH HHS KL2 TR002536NIMH NIH HHS R01 MH111578NIMH NIH HHS T32 MH019113
6 · The paper itself

Abstract

The precise and timely development of the cerebellum is crucial not only for accurate motor coordination and balance but also for cognition. In addition, disruption in cerebellar development has been implicated in many neurodevelopmental disorders, including autism, attention deficit-hyperactivity disorder (ADHD), and schizophrenia. Investigations of cerebellar development in humans have previously only been possible through post-mortem studies or neuroimaging, yet these methods are not sufficient for understanding the molecular and cellular changes occurring in vivo during early development, which is when many neurodevelopmental disorders originate. The emergence of techniques to generate human-induced pluripotent stem cells (iPSCs) from somatic cells and the ability to further re-differentiate iPSCs into neurons have paved the way for in vitro modeling of early brain development. The present study provides simplified steps toward generating cerebellar cells for applications that require a 2-dimensional (2D) monolayer structure. Cerebellar cells representing early developmental stages are derived from human iPSCs via the following steps: first, embryoid bodies are made in 3-dimensional (3D) culture, then they are treated with FGF2 and insulin to promote cerebellar fate specification, and finally, they are terminally differentiated as a monolayer on poly-l-ornithine (PLO)/laminin-coated substrates. At 35 days of differentiation, iPSC-derived cerebellar cell cultures express cerebellar markers including ATOH1, PTF1α, PAX6, and KIRREL2, suggesting that this protocol generates glutamatergic and GABAergic cerebellar neuronal precursors, as well as Purkinje cell progenitors. Moreover, the differentiated cells show distinct neuronal morphology and are positive for immunofluorescence markers of neuronal identity such as TUBB3. These cells express axonal guidance molecules, including semaphorin-4C, plexin-B2, and neuropilin-1, and could serve as a model for investigating the molecular mechanisms of neurite outgrowth and synaptic connectivity. This method generates human cerebellar neurons useful for downstream applications, including gene expression, physiological, and morphological studies requiring 2D monolayer formats.

Indexed as

Induced Pluripotent Stem CellsInsulinsSemaphorinsCell DifferentiationCerebellumFibroblast Growth Factor 2GABAergic NeuronsHumansLamininNeuropilin-1Fibroblast Growth Factor 2InsulinsLamininNeuropilin-1Semaphorins

Identifiers

PMID36190246
PMCPMC10108866
OpenAlexW4296276441

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.